Postoperative breast function and quality of life follow-up study in patients with plasma cell mastitis: a 1-year longitudinal analysis - Report - MDSpire
Advertisement
Postoperative breast function and quality of life follow-up study in patients with plasma cell mastitis: a 1-year longitudinal analysis
Clinical Report: Longitudinal Assessment of Breast Function and Quality of Life After Surgery
Overview
This study evaluates the postoperative outcomes of breast function and quality of life in women with plasma cell mastitis (PCM) over one year. Significant improvements were observed in breast appearance satisfaction, pain intensity, and upper extremity function following surgical intervention.
Background
Plasma cell mastitis is a chronic inflammatory breast disease that can lead to significant morbidity, including pain and cosmetic deformity. Surgical intervention is often necessary, yet the postoperative functional outcomes and quality of life have not been well characterized. Understanding these outcomes is crucial for informed surgical decision-making and patient counseling.
Data Highlights
Outcome
Baseline
12 Months
P-value
BREAST-Q Score
42.38 ± 12.56
68.74 ± 14.23
< 0.001
Pain Score
5.82 ± 2.14
1.45 ± 1.23
< 0.001
Quick-DASH Score
38.67 ± 15.34
12.89 ± 8.76
< 0.001
SF-36 Physical Component Summary
38.45 ± 8.92
48.76 ± 7.34
< 0.001
Key Findings
BREAST-Q scores improved significantly from baseline to 12 months (p < 0.001).
Pain intensity decreased significantly from baseline to 12 months (p < 0.001).
Health-related quality of life (SF-36) improved significantly (p < 0.001).
89.4% achieved minimal clinically important differences in appearance satisfaction at 12 months.
92.3% achieved minimal clinically important differences in pain at 12 months.
Clinical Implications
The findings underscore the effectiveness of surgical intervention for PCM in improving breast function and quality of life. Clinicians should consider these patient-centered outcomes when discussing treatment options with patients, as they reflect meaningful recovery and satisfaction post-surgery.
Conclusion
Surgical treatment for plasma cell mastitis leads to significant and sustained improvements in breast function and quality of life over a one-year period. These results support the role of surgery as a primary treatment modality for PCM.
